Sun Pharma reports consolidated net loss of Rs 219 crore in Q2

14 Nov 2018 Evaluate

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2018.

The company has reported net loss of Rs 906.42 crore for the quarter under review, as against net profit of Rs 577.05 crore for the same quarter in the previous year. However, total income of the company increased by 4.29% at Rs 2,832.22 crore for Q2FY19 as compared Rs 2,715.66 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net loss of Rs 218.82 crore for the quarter under review, as against net profit of Rs 912.12 crore for the same quarter in the previous year. However, total income of the company increased by 5.56% at Rs 7,288.78 crore for Q2FY19 as compared Rs 6,905.18 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.